Human CUL1 forms an evolutionarily conserved ubiquitin ligase - authors library caltech 2026

Get Form
Human CUL1 forms an evolutionarily conserved ubiquitin ligase - authors library caltech Preview on Page 1

Here's how it works

01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

Definition & Meaning

The study titled "Human CUL1 forms an evolutionarily conserved ubiquitin ligase" refers to the analysis of the CUL1 protein in humans. CUL1 acts as a scaffold protein forming part of a ubiquitin ligase complex called the SCF (SKP1, CUL1, F-box protein) complex. This complex is evolutionarily conserved across species, functioning in the ubiquitination process critical for protein degradation. By understanding the CUL1 component, the research delves into crucial mechanisms that regulate cell cycle progression and has implications for therapeutic strategies against diseases like cancer.

Key Elements of the Study

  • CUL1 Protein: Central scaffold component in the ubiquitin ligase complex that interacts with SKP1 and F-box proteins.
  • SCF Complex: A vital structure that regulates protein degradation through ubiquitination.
  • Evolutionary Conservation: Indicates that the complex has been maintained throughout evolution across different species, suggesting its fundamental biological importance.
  • Functional Relevance: The study highlights CUL1's role in complementing yeast mutants, demonstrating functional parallels in cell cycle control between humans and simpler organisms.

How to Obtain the Study

Accessing this study requires visiting institutional libraries that house scientific journals, such as the library at Caltech where the authors are affiliated. Alternatively, searching through academic databases like PubMed or accessing journal websites may provide options to purchase or access the study, possibly behind a paywall.

Legal Use and Ethical Considerations

The information from this study should be used ethically, adhering to copyright laws if materials are reproduced or shared. Direct applications involving therapeutic or experimental approaches require compliance with legal and ethical guidelines governing biomedical research.

Important Terms Related to the Study

  • Ubiquitination: A cellular process where proteins are marked for degradation, controlling protein levels and activity.
  • Cell Cycle Progression: The series of phases that a cell undergoes leading to its division and replication.
  • SIC1: A CDK inhibitor that regulates the cell cycle, specifically targeted by ubiquitin ligases like the SCF complex.
  • F-box Protein: A component of the SCF complex that determines substrate specificity for ubiquitination.

Steps to Utilize Findings

  1. Literature Review: Start with a comprehensive review of existing literature on CUL1 and ubiquitin ligases.
  2. Experimental Design: Develop experimental setups to test CUL1 interactions and SCF complex functionality in cellular models.
  3. Data Analysis: Collect and analyze data concerning cell cycle effects and potential therapeutic implications.
  4. Application: Use insights to inform cancer research strategies, focusing on cell cycle dysregulation and potential drug targets.

Who Typically Uses the Research

This study is valuable to molecular biologists, geneticists, and oncology researchers working on cellular mechanisms and potential drug development. It is also useful for academics teaching protein degradation pathways and their implications in health and disease.

decoration image ratings of Dochub

Examples of Using the Study

In practical laboratory applications, findings from this research can guide experiments on cell cycle regulation in cancer cells, using CUL1 as a target for exploring new cancer treatments. Researchers designing new drugs may utilize the structural information of CUL1-SCF to create molecules that inhibit aberrant cell cycle progression.

State-Specific Rules for Application

While not directly state-specific, applying biotechnological or pharmacological findings derived from such studies involves compliance with federal and state regulations, particularly in clinical trials or therapeutic developments. Institutions must adhere to NIH guidelines and FDA regulations when translating research into clinical practice.

Compatibility with Existing Software Tools

Researchers might rely on bioinformatics tools compatible with platforms like DocHub to digitize and manage data from experiments involving the CUL1 protein. Software like QuickBooks may not directly apply, but robust data management systems are critical for tracking experimental results and compliance with documentation standards.

be ready to get more

Complete this form in 5 minutes or less

Get form

Security and compliance

At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.

Learn more
ccpa2
pci-dss
gdpr-compliance
hipaa
soc-compliance
be ready to get more

Complete this form in 5 minutes or less

Get form